NEW YORK, March 30, 2017 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against FTD Companies, Inc. (“FTD” or the “Company”) (NASDAQ:FTD) and certain of its officers, and is on behalf of purchasers of FTD securities between March 13, 2015 and March 14, 2017, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/ftd.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).
The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) FTD’s financial statements contained errors relating to the assessment of cross-border indirect taxes; (2) as a result, FTD lacked effective internal controls over financial reporting; (3) FTD had overstated the benefits of the Provide acquisition; and (4) consequently, FTD’s public statements were materially false and misleading at all relevant times.
On March 14, 2017, after-market hours, FTD revealed its disappointing financial results for the quarter and year ended December 31, 2016. FTD said in part, that its net loss for the quarter was “primarily due to goodwill impairment charges related to the Provide Commerce segment of $84.0 million”. FTD also said that due to identified errors, it will restate previously reported consolidated financial statements for the years ended December 31, 2015 and 2014 and for the quarters in the years ended December 31, 2015 and 2016. Following this news, FTD stock dropped $5.54, or 23.69%, to close at $17.85 on March 15, 2017.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/ftd or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in FTD you have until May 19, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | [email protected]


U.S. Raises Alarm Over Chinese AI Firms’ Alleged IP Theft Through Model Distillation
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions
PLS Reports Record Lithium Output as EV Demand Fuels Market Growth
Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share
Kakaku.com Stock Surges on EQT Takeover Interest Amid Rising Japan Deal Activity
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast
European Car Sales Surge in March as EV and Hybrid Demand Accelerates
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 



